Glaxo faces U.K. criminal probe on top of China investigation

GlaxoSmithKline (GSK) says it is being investigated by the U.K.'s Serious Fraud Office for possible criminal violations in its commercial practices; no additional information was released.

Separately, GSK is being investigated by authorities in China for allegedly bribing doctors, hospitals and government officials to sell more drugs in that country, and allegations have surfaced of wrongdoing by company employees in Iraq, Poland, Jordan and Lebanon.

In December, GSK announced a global policy to stop paying doctors for giving speeches and attending medical meetings.

From other sites
Comments (1)
  • ejnarlesky
    , contributor
    Comments (30) | Send Message
    Many of you reading this must be feeling the way I do ... I'm so sick and tired of picking what I believe to be a good investment only to find out some time later that the employees at all levels are committing acts subjecting the company to criminal probes/violations and later fines causing the MV to tumble. I wish instead that the employees are held accountable, subjected to the fines and jail.
    28 May 2014, 03:06 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs